CD8A and neoplasm: Other tumor-infiltrated immune cell types, including Treg cells, macrophages and NK cells showed little differences between CUL5 KO and NC (Supplementary Fig. 3f), suggesting the improved therapeutic effect of CUL5 KO CD8+ T cells is largely due to transferred T cells.